AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Clinical trials for AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA trials appear
Sign up with your email to follow new studies for AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to tame blood disorders when other treatments fail
Disease control Recruiting nowThis early study tests a new drug called OM336 in adults with autoimmune cytopenias—conditions where the immune system attacks blood cells. The goal is to check safety and how the body processes the drug. About 32 people whose disease has not responded to at least one prior treat…
Matched conditions: AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE1 • Sponsor: Ouro Medicines • Aim: Disease control
Last updated May 26, 2026 10:12 UTC
-
Engineered immune cells take on tough blood disorder
Disease control Recruiting nowThis study tests a new treatment called CAR-T cell therapy for people with a severe type of autoimmune anemia that hasn't improved with standard treatments. The therapy uses specially modified immune cells from a donor to target and destroy the faulty immune cells causing the dis…
Matched conditions: AIHA - WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: EARLY_PHASE1 • Sponsor: The Second Hospital of Anhui Medical University • Aim: Disease control
Last updated May 22, 2026 13:52 UTC